Literature DB >> 9618612

Health benefits and risks of reporting HIV-infected individuals by name.

G N Colfax1, A B Bindman.   

Abstract

With more treatment options emerging for human immunodeficiency virus (HIV) infection, the policy of reporting HIV-infected individuals by name merits reevaluation. This paper reviews the benefits and risks of name reporting of persons infected with HIV. Public health departments have linked name reporting with medical referrals, risk reduction counseling, and partner notification programs. Yet some studies indicate that people are less likely to be tested for HIV infection when name reporting is implemented. Whether name reporting actually improves individual or public health, therefore justifying the increased risk of loss of confidentiality and possibly reduced testing rates, remains unknown. The lack of health outcome data on name reporting allows beliefs rather than facts to dominate debate about this policy. Before this practice is more widely adopted, a determination should be made as to whether the potential benefits of name reporting outweigh the risks.

Entities:  

Keywords:  Health Care and Public Health; Professional Patient Relationship

Mesh:

Year:  1998        PMID: 9618612      PMCID: PMC1508234          DOI: 10.2105/ajph.88.6.876

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  24 in total

1.  Anonymous HIV testing: does it attract clients who would not seek confidential testing?

Authors:  Tamara Hoxworth; Richard Hoffman; David Cohn; Arthur Davidson
Journal:  AIDS Public Policy J       Date:  1994

2.  A case of relapse with drug-susceptible M. leprae after multidrug therapy.

Authors:  M Constant-Desportes; C C Guelpa-Lauras; J C Carolina; A Léoture; J H Grosset; H Sansarricq
Journal:  Int J Lepr Other Mycobact Dis       Date:  1991-06

3.  Confidential versus anonymous human immunodeficiency virus antibody testing.

Authors:  R E Hoffman; F C Wolf; R C Wood; C Raevsky; T M Vernon
Journal:  West J Med       Date:  1990-01

4.  Mandatory reporting of human immunodeficiency virus testing would deter blacks and Hispanics from being tested.

Authors:  E J Fordyce; S Sambula; R Stoneburner
Journal:  JAMA       Date:  1989-07-21       Impact factor: 56.272

5.  Contact tracing and the control of human immunodeficiency virus infection.

Authors:  G W Rutherford; J M Woo
Journal:  JAMA       Date:  1988-06-24       Impact factor: 56.272

6.  Mandatory reporting of HIV testing would deter men from being tested.

Authors:  S M Kegeles; T J Coates; B Lo; J A Catania
Journal:  JAMA       Date:  1989-03-03       Impact factor: 56.272

7.  The impact of AIDS on state and local health departments: issues and a few answers.

Authors:  F N Judson; T M Vernon
Journal:  Am J Public Health       Date:  1988-04       Impact factor: 9.308

8.  Many people who seek anonymous HIV-antibody testing would avoid it under other circumstances.

Authors:  S M Kegeles; J A Catania; T J Coates; L M Pollack; B Lo
Journal:  AIDS       Date:  1990-06       Impact factor: 4.177

9.  Trial of anonymous versus confidential human immunodeficiency virus testing.

Authors:  L J Fehrs; D Fleming; L R Foster; R O McAlister; V Fox; S Modesitt; R Conrad
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321

10.  Results of a randomized trial of partner notification in cases of HIV infection in North Carolina.

Authors:  S E Landis; V J Schoenbach; D J Weber; M Mittal; B Krishan; K Lewis; G G Koch
Journal:  N Engl J Med       Date:  1992-01-09       Impact factor: 91.245

View more
  5 in total

1.  Name-based reporting of HIV-positive test results as a deterrent to testing.

Authors:  W J Woods; J W Dilley; T Lihatsh; J Sabatino; B Adler; J Rinaldi
Journal:  Am J Public Health       Date:  1999-07       Impact factor: 9.308

2.  Name-based reporting of HIV infection.

Authors:  P M Wortley; J S Lehman; P L Fleming
Journal:  Am J Public Health       Date:  1999-08       Impact factor: 9.308

3.  Anonymous reporting of HIV infection: an evaluation of the HIV/AIDS surveillance system in Norway 1983-2000.

Authors:  P Aavitsland; O Nilsen; A Lystad
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

4.  Women's lives after an HIV-positive diagnosis: disclosure and violence.

Authors:  A C Gielen; K A McDonnell; J G Burke; P O'Campo
Journal:  Matern Child Health J       Date:  2000-06

5.  Estimating HIV prevalence from surveys with low individual consent rates: annealing individual and pooled samples.

Authors:  Lauren Hund; Marcello Pagano
Journal:  Emerg Themes Epidemiol       Date:  2013-02-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.